U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

Increased activity of GSK-3β is directly associated with tau hyperphosphorylation and enhanced production, which leads to molecular dysfunctions, neuronal damage, and cognitive decline in AD.

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company said this morning ...

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts and dual sourcing for its medicines, but offered few details ...

The head of Europe's Airbus called for a return to tariff-free trading for aerospace on Wednesday, joining a chorus of U.S.

U.K. pharmaceutical giant GSK, which also released a quarterly earnings ... its monetary policy around changes being imposed by the White House. "I think we base our decision on what's happening ...

GSK 3β can promote the growth of cancer and confer resistance to chemotherapy. Elraglusib has been shown to overcome chemotherapy resistance and to stimulate immune responses. This study aimed to ...